Tobramycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 39822-0412

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 39822-0412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xgen Pharmaceuticals Djb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Heading (Tobramycin For Injection Usp 1)

FDA Label Image

C:\documents And Settings\junem.x-gen\desktop\spl Submissions\tobramycin Spl\fda Style Sheet\01.jpg (Tobramycin For Injection Usp 2)

FDA Label Image

Table 3 (Tobramycin For Injection Usp 3)

Table 3 (Tobramycin For Injection Usp 3)
This is a dosage guide table for Tobramycin Injection, USP, to be used in adults with normal renal function for serious and life-threatening infections. The dosages vary based on the patient's weight and range from 75mg to 255mg per 8-hour interval. The total daily dosage is 3-5mg per kilogram of body weight. The table is not applicable to the pediatric dosage form of Tobramycin Injection, USP, 10mg/mL.*
FDA Label Image

C:\documents And Settings\junem.x-gen\desktop\spl Submissions\tobramycin Spl\fda Style Sheet\02.jpg (Tobramycin For Injection Usp 4)

C:\documents And Settings\junem.x-gen\desktop\spl Submissions\tobramycin Spl\fda Style Sheet\02.jpg (Tobramycin For Injection Usp 4)
The text describes a reduced dosage nomogram that helps calculate percent of normal dosage based on the patient's creatinine clearance and serum creatinine levels. The nomogram includes values for creatinine clearance ranging from 2 to 80 mL/min/1.73 m2 and serum creatinine levels ranging from 0.5 to 10 mg/100mL. Percent of normal dosage values for each creatinine clearance level are provided in a table. The scales have been adjusted to facilitate dosage calculations.*
FDA Label Image

Tobr-vl-02 (Tobramycin For Injection Usp 5)

FDA Label Image

Tobr-cs-03 (Tobramycin For Injection Usp 6)

Tobr-cs-03 (Tobramycin For Injection Usp 6)
XGen® Pharmaceuticals DJB is a pharmaceutical company.*
FDA Label Image

Tobr-cm-02 (Tobramycin For Injection Usp 7)

Tobr-cm-02 (Tobramycin For Injection Usp 7)
NDC 39822-0412-1 is a pharmacy bulk package of Tobramycin for Injection, USP. Each bottle contains tobramycin sulfate equivalent to 1.2 grams. It is for intravenous use and should be dispensed within 24 hours of entry. It has a usual dosage and preparation of solution procedure which contains single doses. The bottle should be shaken well before withdrawal of the contents which needs to be completed without delay. After reconstitution, it needs to be stored in a refrigerator and used within 96 hours. If kept at room temperature, it can be used within two hours. However, if the text is a medical prescription, it needs to be verified and validated by a licensed pharmacist or physician.*
FDA Label Image

Tobramycin For Injection Usp 8

Tobramycin For Injection Usp 8
Tobramycin for injection is a medicine that comes in a pharmacy bulk package and is not meant for direct infusion. It is for intravenous use only. The xGen® and xcen® brands produce tobramycin in vials of 1.2gm. The NDC code for xGen® is 39822-0412:1, and for xcen® is 39822-04121. The text also includes some unintelligible characters.*
FDA Label Image

Tobramycin For Injection Usp 9

Tobramycin For Injection Usp 9
This is a description of Tobramycin for Injection, USP, a medication packaged in a Six-Pak (6 vials) with an NDC 39822-0412-6. It is not for direct infusion and should only be used for intravenous use. The Pharmacy Bulk Package is also available, and it contains 40 mg of Tobramycin. The text also mentions a Non-coating area and a preparation of the solution. There are some errors and some sentences are incomplete, making the description vague.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.